Discovery of short IL-18 and revelation of its anti-tumor mechanism

 Uncategorized    Friday, 2025/03/14

Meng Guangxun's team from the Chinese Academy of Sciences Shanghai Institute of Immunology and Infection cooperated with Liu Chenying's team from the Xinhua Hospital affiliated to the School of Medicine of Shanghai Jiaotong University, and published a research paper entitled “Short IL-18 generated by caspase-3 cleavage mobilizes NK cells to suppress tumor growth” in the journal Nature Immunology.

This study found that short IL-18 produced by caspase-3 cleavage exerts inhibitory effects on tumor growth by mobilizing NK cells.

Our Related Products

Cat.No. # Product Name Source (Host) Species Tag Protein Length Price
STAT1-2783H Recombinant Human STAT1, His-tagged E.coli Human His 1-712 a.a.
IL18-336H Active Recombinant Human IL18 protein E.coli Human Non
STAT1-7037H Recombinant Human STAT1 protein(Met1-Val712), His&GST-tagged Insect Cells Human GST&His Met1-Val712
IL18-574H Recombinant Human IL18, GST tagged E.coli Human His 1-193 a.a.
CASP3-158H Recombinant Human CASP3 E.coli Human Non 176-277aa
STAT1-2996H Recombinant Human STAT1 protein, GST-tagged E.coli Human GST 2-230 aa
IL18-1237H Active Recombinant Human IL18 Yeast Human Non 157 a.a.
CASP3-1145R Recombinant Rat CASP3 Protein Mammalian Cells Rat His
CASP3-334H Recombinant Human CASP3 protein, GST-tagged Human Human GST 1-277 a.a.
CASP3-26768TH Recombinant Human CASP3 E.coli Human Non
IL18-1942H Recombinant Human IL18 protein E.coli Human Non 1-193aa

In this new study, the research team found that cysteine protease-3 (caspase-3) cleaves IL-18 in cancer cells to produce a 15 kDa form of IL-18, which the team refers to as Short IL-18.

Unlike mature IL-18, short IL-18 is not secreted into the extracellular space and does not bind to IL-18 receptor alpha (IL-18R alpha); On the contrary, it enters the nucleus and promotes the phosphorylation of STAT1 at the serine 727 site (Ser727) through cyclin dependent kinase 8 (CDK8), enhancing the expression and secretion of ISG15.

Discovery of short IL-18 and revelation of its anti-tumor mechanism

This signaling cascade in cancer cells can mobilize natural killer (NK) cells, enhance their cytotoxic effects, and eliminate various syngeneic tumors and colitis related colorectal cancer in mice. In addition, the research team also found that if the nuclei of colorectal cancer patients are rich in short IL-18, their prognosis is better.

Overall, this study highlights a unique anti-tumor pathway driven by short IL-18, where caspase-3 cleavage produces short IL-18, which mobilizes natural killer (NK) cells, enhances their cytotoxic effects, and inhibits tumor growth.

Related Products and Services


PROTAC Targets
Cell and Gene Therapy
Targets of CAR-T Cell Therapy
Cancer Drug Targets
Immune Checkpoint Proteins
Protein Engineering Services
Protein Interaction Service
Protein Expression and Purification Services
Drug Discovery Screening
Protein Pathway Profiling

Reference
Shen, J., Zhang, Y., Tang, W., Yang, M., Cheng, T., Chen, Y., Yu, S., Guo, Q., Cao, L., Wang, X., Xiao, H., Wang, L., Wang, C., Liu, C., & Meng, G. (2025). Short IL-18 generated by caspase-3 cleavage mobilizes NK cells to suppress tumor growth. Nature Immunology, 26(3), 416-428. https://doi.org/10.1038/s41590-024-02074-7